Synergistic Effect of Linezolid Incorporated Chitosan Nanoparticles in Restorative Dental Cements – A Promising Dental Formulation.
Life Sciences-Dental
DOI:
https://doi.org/10.22376/ijlpr.2023.13.5.L209-L217Keywords:
Chitosan, Nanoparticles, linezolid, Antibacterial, Cements, Biocompatibility, Drug delivery.Abstract
Chitosan is considered one of the best materials for use as a drug delivery vehicle. Chitosan is incorporated into dental cement to enhance its properties. Previous investigators have found its antibacterial activity near dental restorations, which was insufficient to produce a clinically significant effect. Hence, the incorporation of various antibacterial agents was proposed. Linezolid is one of the oldest drugs in the oxazolidinone antibiotics category, approved by the US FDA in 2000. It is used to treat various antibiotic-resistant bacterial infections. However, there needs to be more literature regarding using linezolid with chitosan. Current research aims to prepare and characterize chitosan nanoparticles with linezolid for use in dental cement. Chitosan nanoparticles were prepared using the ionotropic gelation technique. They were incorporated with Linezolid, and samples were analyzedby FTIR spectroscopy, Particle size analysis, Transmission Electron Microscopy, High-performance liquid chromatography analysis, antibacterial activity, and biocompatibility. Linezolid was successfully incorporated into chitosan. Chitosan's FTIR spectrum reflected the functional groups present in chitosan, and their peaks were superimposed in the presence of linezolid. Both chitosan and chitosan with linezolid had similar particlesizes (142nm). Linezolid was released from chitosan effectively on the 1st and 7th days (19.78 and 144.14μg/ml). The formulation showed antibacterial activity and was not cytotoxic to cells. Thus prepared linezolid incorporated chitosan is a promising material to be used as an antimicrobial agent in dental cement. Its bio-physico-chemical properties are promising for use in dental cement. In the future, these linezolid-loaded chitosan nanoparticles may be added to various restorative materials.
References
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS et al. Nano-based drug delivery systems: recent developments and prospects. J Nanobiotechnology. 2018;16(1):71. doi: 10.1186/s12951-018-0392-8. PMID 30231877.
Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017 Nov 20;9(4):53. doi: 10.3390/pharmaceutics9040053, PMID 29156634.
Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo). 2010 Nov;58(11):1423-30. doi: 10.1248/cpb.58.1423, PMID 21048331.
Debnath A, Kesavappa SB, Singh GP, Eshwar S, Jain V, Swamy M et al. Comparative evaluation of antibacterial and adhesive properties of chitosan modified glass ionomer cement and conventional glass ionomer cement: an in vitro study. J Clin Diagn Res. 2017 Mar;11(3): ZC75-8. doi: 10.7860/JCDR/2017/25927.9593, PMID 28511515.
Sorlier P, Denuzière A, Viton C, Domard A. Relation between the degree of acetylation and the electrostatic properties of chitin and chitosan. Biomacromolecules. 2001 Fall;2(3):765-72. doi: 10.1021/bm015531+, PMID 11710030.
Vårum KM, Ottøy MH, Smidsrød O. Water-solubility of partially N-acetylated chitosans as a function of pH: effect of chemical composition and depolymerisation. Carbohydr Polym. 1994;25(2):65-70. doi: 10.1016/0144-8617(94)90140-6.
Hashemian SMR, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther. 2018 Jun 18;12:1759-67. doi: 10.2147/DDDT.S164515, PMID 29950810.
Teaima MH, Elasaly MK, Omar SA, El-Nabarawi MA, Shoueir KR. Eco-friendly synthesis of functionalized chitosan-based nanoantibiotic system for potential delivery of linezolid as antimicrobial agents. Saudi Pharm J. 2020 Jul;28(7):859-68. doi: 10.1016/j.jsps.2020.06.005, PMID 32647488.
Teaima MH, Elasaly MK, Omar SA, El-Nabarawi MA, Shoueir KR. Wound healing activities of polyurethane modified chitosan nanofibers loaded with different concentrations of linezolid in an experimental model of diabetes. J Drug Deliv Sci Technol. 2022 Jan 1;67:102982. doi: 10.1016/j.jddst.2021.102982.
Ghataty DS, Amer RI, Wasfi R, Shamma RN. Novel linezolid loaded bio-composite films as dressings for effective wound healing: experimental design, development, optimization, and antimicrobial activity. Drug Deliv. 2022 Dec;29(1):3168-85. doi: 10.1080/10717544.2022.2127974, PMID 36184799.
Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym. 2008 Jul 4;73(1):44-54. doi: 10.1016/J.carbpol.2007.11.007.
Fernandes Queiroz M, Melo KR, Sabry DA, Sassaki GL, Rocha HA. Does the use of chitosan contribute to oxalate kidney stone formation? Mar Drugs. 2014 Dec 29;13(1):141-58. doi: 10.3390/md13010141, PMID 25551781.
Varma R, Vasudevan S. Extraction, characterization, and antimicrobial activity of chitosan from horse mussel modiolus Modiolus. ACS Omega. 2020 Aug 6;5(32):20224-30. doi: 10.1021/acsomega.0c01903, PMID 32832775.
Reddy PK, Mukkanti K, Rao DM. A novel synthesis of oxazolidinone derivatives (a key intermediate of linezolid). Orientjchem. 2013;29(3):1015-9. doi: 10.13005/ojc/290322.
Nidam T, Braude V, Adlerm M, Ramaty R. Isolated bis-linezolid, preparation thereof, and its use as a reference standard. US20060252932: 2006.
Khan A, Ahmad S, Ahmad I, Rizvi M. Anti-proliferative activity of curcumin loaded PLGA nanoparticles for prostate cancer. In Nanotechnology applied to pharmaceutical technology 2017 (pp. 267-78). Berlin: Springer.
Kahdestani SA, Shahriari MH, Abdouss M. Synthesis and characterization of chitosan nanoparticles containing teicoplanin using sol–gel. Polym Bull. 2021 Feb;78(2):1133-48. doi: 10.1007/s00289-020-03134-2.
Sreekumar S, Goycoolea FM, Moerschbacher BM, Rivera-Rodriguez GR. Parameters influencing the size of chitosan-TPP Nano-and microparticles. Sci Rep. 2018 Mar 16;8(1):1-.
Ghadi A, Mahjoub S, Tabandeh F, Talebnia F. Synthesis and optimization of chitosan nanoparticles: potential applications in nanomedicine and biomedical engineering. Caspian J Intern Med. 2014 Summer;5(3):156-61. PMID 25202443.
Souza TGF, Ciminelli VST, Mohallem NDS. A comparison of TEM and DLS methods to characterize the size distribution of ceramic nanoparticles. J Phys.: Conf Ser. 2016;733(1):012039. doi: 10.1088/1742-6596/733/1/012039.
Kalam MA, Iqbal M, Alshememry A, Alkholief M, Alshamsan A. Development and evaluation of chitosan nanoparticles for ocular delivery of tedizolid phosphate. Molecules. 2022 Apr 4;27(7):2326. doi: 10.3390/molecules27072326, PMID 35408724.
Bin-Jumah M, Gilani SJ, Jahangir MA, Zafar A, Alshehri S, Yasir M et al. Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity. Int J Nanomedicine. 2020 Oct 13;15:7861-75. doi: 10.2147/IJN.S269004, PMID 33116505.
Soltanzadeh M, Peighambardoust SH, Ghanbarzadeh B, Mohammadi M, Lorenzo JM. Chitosan nanoparticles encapsulating lemongrass (Cymbopogon commutatus) essential oil: physicochemical, structural, antimicrobial and in-vitro release properties. Int J Biol Macromol. 2021 Dec 1;192:1084-97. doi: 10.1016/j.ijbiomac.2021.10.070, PMID 34673101.
Mikušová V, Mikuš P. Advances in chitosan-based nanoparticles for drug delivery. Int J Mol Sci. 2021 Sep 6;22(17):9652. doi: 10.3390/ijms22179652, PMID 34502560.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Omar Farooq Burhanuddin Mohammed, Muthukrishnan Lakshmipathy, N. Somasundaram Mohan Kumar, M.S. Nivedhitha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.